The bleak outlook on ovarian cancer.
Dugan
K K
KK
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000451:nursing / Q000473:pathology / Q000628:therapy*; D010166:Palliative Care; D011379:Prognosis
D000970:Antineoplastic Agents